Rallybio Corp (RLYB) shareholders
Close on Nov 17, 2026Market cap $82.32MP/E 3.4Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Viking Global Opportunities Portfolio GP LLC Joint filing with Viking Global Investors LP (9.99%), Viking Global Opportunities Parent GP LLC (9.99%) and 5 more | 4,222,969 | 9.99% | 13G (passive) amendment | Dec 31, 2025 |
| Pivotal bioVenture Partners Fund I, L.P. Joint filing with Nan Fung Group Holdings Limited (6.40%), NF Investment Holdings Limited (6.40%) and 5 more | 2,404,644 | 6.40% | 13D (active) amendment | Feb 12, 2024 |
| ADAR1 Capital Management, LLC Joint filing with Daniel Schneeberger (17.50%) | 926,352 | 17.50% | 13G (passive) | May 31, 2026 |
| Abigail P. Johnson Joint filing with FMR LLC (15.00%) | 794,720 | 15.00% | 13G (passive) amendment | Jun 30, 2026 |
| Viking Global Opportunities Parent GP LLC Joint filing with Viking Global Investors LP (9.99%), Viking Global Opportunities GP LLC (9.99%) and 4 more | 528,954 | 9.99% | 13G (passive) amendment | Mar 31, 2026 |
| James G. Coulter Joint filing with Tpg Gp A, LLC (7.20%), Jon Winkelried (7.20%) | 378,551 | 7.20% | 13D (active) amendment | Mar 1, 2026 |
| Dames GP LLC Joint filing with Balyasny Asset Management L.P. (7.12%), Bam Gp LLC (7.12%) and 2 more | 376,573 | 7.12% | 13G (passive) | Mar 31, 2026 |
| Laurion Capital Management LP Joint filing with Benjamin Alexander Smith (5.72%), Janaka Sheehan Maduraperuma (5.72%) | 302,756 | 5.72% | 13G (passive) | Mar 31, 2026 |
| Kush Parmar Joint filing with Andrew J. Schwab (5.50%) | 291,788 | 5.50% | 13D (active) amendment | Feb 25, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of RLYB | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 7,705,787 | 143.13% | $12.73M | +7,685,901 | 0.00% |
| ADAR1 Capital Management, LLC | 926,352 | 17.21% | $14.82M | +905,817 | 0.68% |
| FMR LLC | 794,720 | 14.76% | $12.72M | +1,269 | 0.00% |
| Viking Global Investors LP | 524,347 | 9.74% | $8.39M | – | 0.02% |
| Tpg Gp A, LLC | 378,551 | 7.03% | $6.06M | – | 0.12% |
| Nantahala Capital Management, LLC | 376,844 | 7.00% | $6.03M | +76,209 | 0.10% |
| Pivotal bioVenture Partners Investment Advisor LLC | 300,579 | 5.58% | $4.81M | – | 1.56% |
| Renaissance Technologies LLC | 199,907 | 3.71% | $3.20M | +43,380 | 0.00% |
| Vanguard Capital Management LLC | 172,497 | 3.20% | $2.76M | +60,457 | 0.00% |
| Almitas Capital LLC | 120,682 | 2.24% | $1.93M | −70,524 | 0.46% |
| Rangeley Capital, LLC | 104,850 | 1.95% | $1.68M | +74,720 | 1.53% |
| Mariner, LLC | 50,566 | 0.94% | $809.06K | – | 0.00% |
| Jane Street Group, LLC | 47,423 | 0.88% | $758.77K | New | 0.00% |
| Geode Capital Management, LLC | 32,047 | 0.60% | $512.87K | −3,378 | 0.00% |
| BlackRock, Inc. | 30,332 | 0.56% | $485.31K | +12,846 | 0.00% |
| Hrt Financial LP | 25,657 | 0.48% | $410.00K | New | 0.00% |
| XTX Topco Ltd | 21,497 | 0.40% | $343.95K | +10,271 | 0.00% |
| Vanguard Fiduciary Trust Co | 16,820 | 0.31% | $269.12K | +3,273 | 0.00% |
| Two Sigma Investments, LP | 16,619 | 0.31% | $265.90K | New | 0.00% |
| State Street Corp | 12,996 | 0.24% | $207.94K | New | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 37 | 12M | 100.0% | 9 / 10 | 6 / 10 | 9M | 2M |
| Q1 2026 | 38 | 5M | 86.7% | 13 / 7 | 16 / 20 | 2M | 1M |
| Q4 2025 | 46 | 3M | 57.9% | 4 / 7 | 11 / 2 | 0M | 0M |
| Q3 2025 | 45 | 4M | 69.3% | 6 / 9 | 11 / 9 | 0M | 0M |
| Q2 2025 | 48 | 4M | 72.4% | 7 / 8 | 12 / 6 | 0M | 0M |
| Q1 2025 | 47 | 4M | 74.3% | 2 / 9 | 14 / 4 | 0M | 0M |
| Q4 2024 | 49 | 4M | 75.3% | 7 / 12 | 11 / 7 | 0M | 0M |
| Q3 2024 | 49 | 4M | 72.5% | 2 / 11 | 21 / 18 | 0M | 0M |
| Q2 2024 | 66 | 4M | 73.4% | 21 / 13 | 17 / 17 | 1M | 0M |
| Q1 2024 | 62 | 4M | 70.5% | 13 / 16 | 16 / 5 | 0M | 0M |
| Q4 2023 | 54 | 4M | 74.0% | 9 / 20 | 10 / 12 | 0M | 0M |
| Q3 2023 | 58 | 4M | 72.4% | 5 / 13 | 14 / 5 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
15 funds held RLYB in Q2 2026, 34% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of RLYB | Value | % of fund | As of |
|---|---|---|---|---|---|
| Fidelity Growth Company Fund | 207,668 | 3.86% | $3.00M | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 134,620 | 2.50% | $2.15M | 0.00% | Jun 30, 2026 |
| Fidelity Growth Company K6 Fund | 56,522 | 1.05% | $817.31K | 0.00% | May 31, 2026 |
| Fidelity Series Growth Company Fund | 53,600 | 1.00% | $775.06K | 0.00% | May 31, 2026 |
| Vanguard Extended Market Index Fund | 32,447 | 0.60% | $519.15K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 16,252 | 0.30% | $235.00K | 0.00% | May 31, 2026 |
| iShares Micro-Cap ETF | 11,832 | 0.22% | $189.31K | 0.01% | Jun 30, 2026 |
| Dimensional U.S. Small Cap ETF | 6,675 | 0.12% | $106.33K | 0.00% | Jul 31, 2026 |
| U.S. Micro Cap Portfolio | 4,605 | 0.09% | $73.36K | 0.00% | Jul 31, 2026 |
| Fidelity Series Total Market Index Fund | 4,508 | 0.08% | $65.19K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 4,079 | 0.08% | $58.98K | 0.00% | May 31, 2026 |
| Vanguard Institutional Total Stock Market Index Fund | 3,141 | 0.06% | $50.26K | 0.00% | Jun 30, 2026 |
| Fidelity Nasdaq Composite Index Fund | 3,003 | 0.06% | $43.42K | 0.00% | May 31, 2026 |
| Vanguard Balanced Index Fund | 2,289 | 0.04% | $36.62K | 0.00% | Jun 30, 2026 |
| 1290 VT Micro Cap Portfolio | 795 | 0.01% | $12.72K | 0.01% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Stephen Uden | Chief Executive Officer, Director | 148,864 | 2.76% | Oct 29, 2026 |
| Jonathan I. Lieber | Chief Financial Officer | 44,139 | 0.82% | Nov 3, 2026 |
| Steven Ryder | Chief Medical Officer | 192,370 | 3.57% | Feb 19, 2025 |
| Ronald Hunt | Director | 2,330,728 | 43.29% | Nov 5, 2026 |
| Martin Mackay | Director | 561,549 | 10.43% | Nov 5, 2026 |
| Christine A. Nash | Director | 3,562 | 0.07% | Oct 30, 2026 |
| Wendy Chung | Director | 5,624 | 0.10% | Oct 28, 2026 |
| Helen M. Boudreau | Director | 8,604 | 0.16% | Oct 20, 2026 |
| Paula Soteropoulos | Director | 6,544 | 0.12% | Oct 20, 2026 |
| Robert Lorne Hopfner | Director | 2,282,231 | 42.39% | Oct 14, 2026 |
| Hui Liu | Director | 3,562 | 0.07% | Sep 28, 2026 |
| ADAR1 Capital Management, LLC | 10% owner | 926,352 | 17.21% | May 20, 2026 |
| Daniel Schneeberger | 10% owner | 909,943 | 16.90% | May 20, 2026 |
| Llc Fmr | 10% owner | 211,798 | 3.93% | Mar 10, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Ronald Hunt Director | Nov 4, 2026 | Option exercise | +14,305 | $4.45 | $63.66K | 29,125 |
| Martin Mackay Director | Nov 4, 2026 | Option exercise | +18,055 | $4.45 | $80.34K | 125,032 |
| Martin Mackay Director | Nov 4, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 106,977 |
| Martin Mackay Director | Nov 4, 2026 | Option exercise | +11,607 | $7.60 | $88.21K | 103,415 |
| Jonathan I. Lieber Chief Financial Officer | Nov 2, 2026 | Option exercise | +7,124 | $14.88 | $106.01K | 44,139 |
| Jonathan I. Lieber Chief Financial Officer | Oct 29, 2026 | Option exercise | +13,589 | $6.08 | $82.62K | 37,015 |
| Jonathan I. Lieber Chief Financial Officer | Oct 29, 2026 | Option exercise | +7,875 | $14.88 | $117.18K | 23,426 |
| Ronald Hunt Director | Oct 29, 2026 | Option exercise | +2,062 | $15.28 | $31.51K | 14,820 |
| Ronald Hunt Director | Oct 29, 2026 | Option exercise | +9,196 | $7.60 | $69.89K | 12,758 |
| Ronald Hunt Director | Oct 29, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 3,562 |
| Christine A. Nash Director | Oct 28, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 3,562 |
| Stephen Uden Chief Executive Officer, Director | Oct 27, 2026 | Option exercise | +33,244 | $6.08 | $202.12K | 148,864 |
| Jonathan I. Lieber Chief Financial Officer | Oct 27, 2026 | Sale | −599 | $16.04 | $9.61K | 15,551 |
| Jonathan I. Lieber Chief Financial Officer | Oct 26, 2026 | Award | +2,500 | – | – | 16,150 |
| Wendy Chung Director | Oct 26, 2026 | Option exercise | +2,062 | $15.28 | $31.51K | 5,624 |
| Paula Soteropoulos Director | Oct 16, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 6,544 |
| Helen M. Boudreau Director | Oct 16, 2026 | Option exercise | +2,062 | $15.28 | $31.51K | 8,604 |
| Robert Lorne Hopfner Director | Oct 12, 2026 | Option exercise | +2,062 | $15.28 | $31.51K | 14,820 |
| Robert Lorne Hopfner Director | Oct 12, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 12,758 |
| Robert Lorne Hopfner Director | Oct 12, 2026 | Option exercise | +9,196 | $7.60 | $69.89K | 9,196 |
| Jonathan I. Lieber Chief Financial Officer | Oct 9, 2026 | Option exercise | +3,910 | $6.08 | $23.77K | 13,650 |
| Stephen Uden Chief Executive Officer, Director | Oct 6, 2026 | Option exercise | +22,456 | $6.08 | $136.53K | 115,620 |
| Jonathan I. Lieber Chief Financial Officer | Sep 29, 2026 | Option exercise | +5,000 | $6.08 | $30.40K | 9,740 |
| Hui Liu Director | Sep 24, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 3,562 |
| Hui Liu Director | Sep 24, 2026 | Option exercise | +8,482 | $7.60 | $64.46K | 12,044 |
| Wendy Chung Director | Sep 16, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 3,562 |
| Helen M. Boudreau Director | Jul 6, 2026 | Option exercise | +3,562 | $2.38 | $8.48K | 6,542 |
| ADAR1 Capital Management, LLC 10% owner | May 19, 2026 | Buy | +200 | $13.80 | $2.76K | 926,352 |
| ADAR1 Capital Management, LLC 10% owner | May 19, 2026 | Buy | +10,000 | $13.98 | $139.80K | 926,152 |
| ADAR1 Capital Management, LLC 10% owner | May 18, 2026 | Buy | +6,009 | $13.98 | $84.01K | 916,152 |
| Daniel Schneeberger 10% owner | May 15, 2026 | Buy | +100 | $13.80 | $1.38K | 909,943 |
| Daniel Schneeberger 10% owner | May 15, 2026 | Buy | +200 | $13.95 | $2.79K | 910,143 |
| Daniel Schneeberger 10% owner | May 13, 2026 | Buy | +75,178 | $14.00 | $1.05M | 909,843 |
| Daniel Schneeberger 10% owner | May 13, 2026 | Buy | +4,081 | $13.80 | $56.32K | 834,665 |
| ADAR1 Capital Management, LLC 10% owner | May 12, 2026 | Buy | +800 | $13.83 | $11.06K | 830,584 |
| ADAR1 Capital Management, LLC 10% owner | May 11, 2026 | Buy | +19,900 | $14.00 | $278.60K | 829,784 |
| ADAR1 Capital Management, LLC 10% owner | May 11, 2026 | Buy | +5,100 | $14.00 | $71.40K | 784,884 |
| ADAR1 Capital Management, LLC 10% owner | May 11, 2026 | Buy | +25,000 | $14.00 | $350.00K | 809,884 |
| Daniel Schneeberger 10% owner | May 5, 2026 | Buy | +35,101 | $14.00 | $491.41K | 779,784 |
| Daniel Schneeberger 10% owner | May 4, 2026 | Buy | +116,904 | $13.97 | $1.63M | 744,683 |
| Daniel Schneeberger 10% owner | May 4, 2026 | Buy | +3,900 | $13.90 | $54.21K | 627,779 |
| Jonathan I. Lieber Chief Financial Officer | Feb 23, 2026 | Sale | −789 | $5.06 | $3.99K | 4,115 |
| Jonathan I. Lieber Chief Financial Officer | Feb 18, 2026 | Award | +2,500 | – | – | 4,904 |
| Jonathan I. Lieber See Remarks | Mar 14, 2023 | Buy | +5,000 | $5.21 | $26.05K | 5,000 |
| Kush Parmar Director | Mar 7, 2023 | Sale | −100,000 | $8.20 | $820.00K | 2,378,969 |
| Andrew J. Schwab 10% owner | Mar 7, 2023 | Sale | −100,000 | $8.20 | $820.00K | 2,378,969 |
| Kush Parmar Director, 10% owner | Jun 3, 2022 | Sale | −50,329 | $12.50 | $629.11K | 1,251,755 |
| Kush Parmar Director, 10% owner | Jun 3, 2022 | Sale | −99,671 | $12.50 | $1.25M | 2,478,969 |
| 5AM Partners V, LLC 10% owner | Jun 3, 2022 | Sale | −99,671 | $12.50 | $1.25M | 2,478,969 |
| 5AM Partners V, LLC 10% owner | Jun 3, 2022 | Sale | −50,329 | $12.50 | $629.11K | 1,251,755 |
| 5AM Partners V, LLC 10% owner | May 23, 2022 | Sale | −66,447 | $13.00 | $863.81K | 2,578,640 |
| 5AM Partners V, LLC 10% owner | May 23, 2022 | Sale | −33,553 | $13.00 | $436.19K | 1,302,084 |
| Kush Parmar Director, 10% owner | May 23, 2022 | Sale | −33,553 | $13.00 | $436.19K | 1,302,084 |
| Kush Parmar Director, 10% owner | May 23, 2022 | Sale | −66,447 | $13.00 | $863.81K | 2,578,640 |
| Jeffrey M. Fryer See Remarks | Mar 21, 2022 | Buy | +3,000 | $8.04 | $24.12K | 47,048 |
| Kush Parmar Director | Feb 8, 2022 | Sale | −70,461 | $13.05 | $919.52K | 1,335,637 |
| Kush Parmar Director | Feb 8, 2022 | Sale | −139,539 | $13.05 | $1.82M | 2,645,087 |
| 5AM Ventures V, L.P. 10% owner | Feb 8, 2022 | Sale | −70,461 | $13.05 | $919.52K | 1,335,637 |
| 5AM Ventures V, L.P. 10% owner | Feb 8, 2022 | Sale | −139,539 | $13.05 | $1.82M | 2,645,087 |
| Jeffrey M. Fryer See Remarks | Jan 19, 2022 | Buy | +1,400 | $8.70 | $12.18K | 44,048 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Rallybio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,213 shares on Sep 2, 2026 over the last 90 days.
See a number that looks wrong?